1. Kerner JC: Vergiftung durch verdorbene Wuerste. Tuebinger Blaetter Naturwissenschaften Arzneykunde3:1,1817

2. Van Ermengen E: Ueber einen neuen anaeroben Bacillus und seine Beziehung zum Botulismus. J Hyg Infektionskrankh26:1,1897

3. Schantz EJ and Johnson EA: botulinum toxin the story of its development of human disease. Perspectives Biol Med 40:317, 1997

4. Burgen A, Dickens F and Zatman LJ: The action of botulinum toxin on the neuromuscular junction. J Physiol 109:10,1949

5. Scott AB, Rosenbaum A and Collins CC: Pharmacologic weakening of extraocular muscles. Invest Opthalmol 12:924,1973

6. Scott AB: Clostrial toxins as therapeutic agents In: Simpson LL,ed. Botulinum Neurotoxin and tetanus toxin.new York :Academic press,1989: p399.

7. Carruthers J and Carruthers A: Botulinum toxin use on Glabells wrinkles. Presented at the annual meeting of the American Society for dermatologic surgery Orlando florida. March, 13,1991

8. Carrhthers J and Carruther A: Treatment of glabellar frawn lines with C. botulinum-A exotoxin. J Dermatol Surg Oncolo 18: 17,1992

9. Greene PE and Fahn S: Response to botulinum toxin F in seronegative botulinum toxin A resistant patients Mov Disord 11: 181,1996

10. Das Gupta BR and Sugiyama H: biochemistry and pharmacology of botulinum and tetanus neurotoxins. In: Bernheimer AW,ed. Perspectives in toxicology New York:Wiley,1977: 87

11. Becker-Wegerich P,Rauch L and Ruzicka T: Botulinum toxin A in the therapy of mimic facial lines Clinical and experimental dermatology 26:619,2001

12. Borodic G, Johnson E, Goodnough M and Schantz E Botulinum toxin therapy,immunologic resistance, and problems with available materials. Neurology 46: 26,1996

13. Claude Le Louarn: Botulinum Toxin A and Facial Lines: The variable concentration Aesth Plast Surg 25:73,2001